Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Prolocor has raised $1.7M in total funding. The most recent round was Convertible Note. The last funding was announced in February 2024.
Prolocor's investors include LabCorp, LabCorp Venture Fund, Small Business Innovation Research, Green Park & Golf Ventures.
Prolocor is headquartered in Philadelphia, United States.
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Prolocor is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prolocor — Funding & Investors." VCBacked, February 27, 2024, https://www.vcbacked.co/company/prolocor. Accessed August 14, 2026.
VCBacked. (2024). Prolocor — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/prolocor
{{cite web |title=Prolocor — Funding & Investors |url=https://www.vcbacked.co/company/prolocor |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated